(MedPage Today) — SAN FRANCISCO — Patients with a history of GLP-1 receptor agonist treatment had a significantly lower risk of developing colorectal cancer (CRC) as compared with those who took aspirin, according to a retrospective study reported…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.












